Actuated Medical Expands Expertise in Forensic DNA Analysis with Acquisition of Mitotyping Technologies LLC
Mitotyping Technologies LLC has established itself as a trailblazer in the DNA forensic industry, providing cutting-edge solutions for mitochondrial DNA analysis for over 24 years. The acquisition aligns with Actuated Medical's vision to explore new avenues of innovation and leverage its expertise in precision engineering for applications beyond the medical field.
"We are excited to welcome Mitotyping Technologies into the Actuated Medical family," said Maureen L. Mulvihill, CEO and Founder of Actuated Medical. "This strategic acquisition not only strengthens our portfolio but also positions us at the forefront of forensic mitochondrial DNA analysis. Mitotyping Technologies has a stellar reputation for delivering high-quality results, and we look forward to integrating their expertise into our broader mission of advancing science and technology."
Mitotyping Technologies is known for its team of highly skilled scientists and exceptional success rate when working with minute, aged, and highly degraded samples. Using a unique, customized casework approach, Mitotyping Technologies has been instrumental in numerous forensic investigations. This acquisition enables Actuated Medical to leverage Mitotyping Technologies' extensive experience and established relationships within the forensic community.
"We are thrilled to join forces with Actuated Medical, a company known for its commitment to excellence and innovation,"
The integration of Mitotyping Technologies into Actuated Medical's portfolio enhances the company's ability to address the growing demand for advanced forensic DNA solutions. The combined resources, knowledge, and technologies will empower Actuated Medical to make significant contributions to the field of forensic science.
About Actuated Medical:
Actuated Medical is a medical device product innovator with an impressive portfolio boasting six FDA 510(k) clearances, over 41 US and International patents, and three products already making waves in early sales. Their unwavering focus on neuroscience, gastrointestinal, critical care, and pediatrics is reshaping the landscape of medical technology. Operating from a cutting-edge 20,000sq.ft. facility in central Pennsylvania, their ISO 13485 and WOSB certifications underscore their commitment to quality. Honored with two SBA Tibbets Awards for SBIR commercialization excellence and the 2020 Life Sciences PA CEO of the Year award, Actuated's remarkable journey includes a pivotal role in addressing the PPE shortage during the COVID crisis.
About Mitotyping Technologies LLC:
Mitotyping Technologies, based in the vibrant State College area, shattered the myth surrounding the legendary Wild Bill Longley with an exuberant triumph. While Texas folklore hinted at his elusive escape from the hangman's noose three times, Mitotyping Technologies definitively debunked the tale, proving his identity through forensic Mitochondrial DNA analysis. As a global leader in this field for over 20 years, their accredited DNA forensic laboratory has been instrumental in active criminal cases, post-conviction exonerations, cold cases, maternal relatedness, and missing persons investigations. Their unparalleled expertise extends to achieving superior recovery rates for mitochondrial DNA even in the most challenging samples. Mitotyping Technologies doesn't just solve cases; they redefine what's possible in forensic science with unmatched enthusiasm and dedication.
For media inquiries, please contact: Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at email@example.com.
Additional information can be found by visiting: